Breaking News Instant updates and real-time market news.

TEVA

Teva

$9.91

0.31 (3.23%)

, SENS

Senseonics

$1.82

-0.06 (-3.19%)

10:21
07/05/19
07/05
10:21
07/05/19
10:21

Fly Intel: Top five analyst actions

Catch up on today's top five analyst actions with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Buy from Hold at Argus with analyst Jason McCarthy saying the company has been making progress in resolving its "numerous challenges" of the past several years. 2. Senseonics (SENS) downgraded to Market Perform from Outperform at Raymond James with analyst Jayson Bedford stating the company's "persistent headwinds" leave him "less patient" with respect to the shares. 3.Omnova Solutions (OMN) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter saying he believes Synthomer paid a "fair but full price" to acquire Omnova and that a competing bidder is unlikely to emerge. 4. Mercer (MERC) downgraded to Neutral from Outperformer at CIBC. 5. BASF (BASFY) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TEVA

Teva

$9.91

0.31 (3.23%)

SENS

Senseonics

$1.82

-0.06 (-3.19%)

OMN

Omnova Solutions

$9.95

0.05 (0.51%)

MERC

Mercer

$14.94

-0.3 (-1.97%)

BASFY

BASF

$0.00

(0.00%)

  • 07

    Aug

  • 09

    Sep

  • 25

    Sep

TEVA Teva
$9.91

0.31 (3.23%)

07/05/19
07/05/19
UPGRADE
Target $12

Buy
Teva upgraded to Buy from Hold at Argus
As previously reported, Argus analyst Jason McCarthy upgraded Teva to Buy with a price target of $12, saying the company has been making progress in resolving its "numerous challenges" of the past several years. The analyst believes that the company's reliance on Copaxone has declined and its cost base has also decreased "significantly", adding that the generics industry overall is also stabilizing. McCarthy further notes that while Teva could be faced with "several more challenging quarters", he sees its current forward earnings multiple of 3.9-times as an "excessive discount" valuation relative to the peer average of 6.7-times and its historical average of 8.6-times.
07/05/19
ARGS
07/05/19
UPGRADE
ARGS
Buy
Teva upgraded to Buy from Hold at Argus
Argus analyst Jason McCarthy upgraded Teva to Buy from Hold.
06/18/19
BERN
06/18/19
NO CHANGE
Target $11
BERN
Market Perform
Bernstein sees 'no reason to own' Teva, lowers price target to $11
Bernstein analyst analyst Ronny Gal said he sees "no reason to own" Teva shares given the company's weak free cash flow, legal overhangs and valuation. He keeps a Market Perform rating on Teva shares and lowered his price target on the stock to $11 from $17.
06/17/19
SBSH
06/17/19
NO CHANGE
Target $13
SBSH
Buy
Citi removes Teva from Focus List on opioid litigation catalysts
Citi analyst Liav Abraham removed Teva Pharmaceutical from her firm's Focus List after cutting her price target for the shares to $13 from $23. Near-term litigation catalysts are unlikely to favor the opioid manufacturers, Abraham tells investors in a research note. The analyst views the upcoming Ohio multi-district litigation, where the court case is scheduled for October 2019, as an important catalyst. At current levels, she believes Teva is pricing in an incremental liability of $5B-$10B. Abraham keeps a Buy rating on Teva.
SENS Senseonics
$1.82

-0.06 (-3.19%)

02/04/19
PIPR
02/04/19
NO CHANGE
Target $2.7
PIPR
Neutral
Piper Jaffray uncertain of benefits from increased Roche access for Senseonics
Piper Jaffray analyst JP Kim kept his Neutral rating and $2.70 price target on Senseonics (SENS) after the company announced an extension of agreement with Roche (RHHBY). The analyst notes that the management is likely willing to trade off the near term price gains for long term volume gain through this deal, but adds that a reset of consensus estimates for sales that would lead to Senseonics becoming a "beat and raise story" is uncertain.
06/06/19
PIPR
06/06/19
NO CHANGE
PIPR
Senseonics receives FDA claim for Eversense CGM system, says Piper Jaffray
Piper Jaffray analyst JP McKim maintained a Neutral rating and $2.70 price target on Senseonics, while noting that the company "received a non-adjunctive claim for their Eversense CGM system" from the FDA. The analyst said that the claim would allow Eversense "to be used in replacement for finger stick glucose measurements" and added that it "is a needed claim to begin the process to unlock the Medicare population and represents an important stage in their commercialization process."
07/05/19
RAJA
07/05/19
DOWNGRADE
RAJA
Market Perform
Senseonics downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Jayson Bedford downgraded Senseonics to Market Perform from Outperform. The analyst says the company's "persistent headwinds" leave him "less patient" with respect to the shares.
01/29/19
PIPR
01/29/19
INITIATION
Target $2.7
PIPR
Neutral
Senseonics initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst JP McKim started Senseonics with a Neutral rating and $2.70 price target. The analyst believes the stock's risk/reward remains balanced over the next 12 months given the "hand to hand combat of reimbursement coverage and at its current 90 day configuration in the U.S."
OMN Omnova Solutions
$9.95

0.05 (0.51%)

07/05/19
DBAB
07/05/19
DOWNGRADE
Target $10.15
DBAB
Hold
Omnova Solutions downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Begleiter downgraded Omnova Solutions to Hold from Buy while raising his price target for the shares to $10.15 from $8.50. The analyst believes Synthomer paid a "fair but full price" to acquire Omnova and that a competing bidder is unlikely to emerge.
07/03/19
SIDC
07/03/19
DOWNGRADE
Target $10
SIDC
Neutral
Omnova Solutions downgraded to Neutral from Buy at Sidoti
Sidoti analyst Edward Marshall downgraded Omnova Solutions to Neutral from Buy and lowered his price target for the shares to $10 from $12 after the company agreed to be acquired by Synthomer for $10.15 per share.
MERC Mercer
$14.94

-0.3 (-1.97%)

07/05/19
CIBC
07/05/19
DOWNGRADE
Target $17
CIBC
Neutral
Mercer downgraded to Neutral from Outperformer at CIBC
CIBC analyst Hamir Patel downgraded Mercer to Neutral from Buy and cut its price target to $17 from $22.
05/06/19
FBCO
05/06/19
NO CHANGE
Target $24
FBCO
Outperform
Mercer price target raised to $24 from $18 at Credit Suisse
10/18/18
RAJA
10/18/18
UPGRADE
RAJA
Strong Buy
Mercer upgraded to Strong Buy from Outperform at Raymond James
BASFY BASF
$0.00

(0.00%)

01/10/19
JPMS
01/10/19
UPGRADE
JPMS
Overweight
BASF upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Chetan Udeshi upgraded BASF to Overweight while lowering his price target for the shares to EUR 74 from EUR 94.
06/14/19
DZBN
06/14/19
DOWNGRADE
DZBN
Hold
BASF downgraded to Hold from Buy at DZ Bank
DZ Bank analyst Peter Spenglerdo downgraded BASF to Hold from Buy and lowered his price target for the shares to 63 euros from 76 euros.
07/05/19
GSCO
07/05/19
INITIATION
GSCO
Neutral
BASF initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Georgina Iwamoto moved from Not Rated to a Neutral rating on BASF, telling investors that she believes the implied second half EBIT growth required to meet the company's guidance will be challenging and she sees increased odds of a guidance reduction, though she also thinks the market is "relatively well-prepared" for such a guidance cut. Iwamoto forecasts FY19 adjusted EBIT to be down 10% year-over-year, which compares to guidance for growth of 1%-10%. She set a price target of EUR71 on BASF shares.
12/07/18
DBAB
12/07/18
NO CHANGE
DBAB
BASF guidance cut not a surprise, says Deutsche Bank
Deutsche Bank analyst Tim Jones views today's guidance cut by BASF as unsurprising. The analyst has a Buy rating on the shares.

TODAY'S FREE FLY STORIES

TCEHY

Tencent

$0.00

(0.00%)

, MDLA

Medallia

$37.09

(0.00%)

07:31
07/21/19
07/21
07:31
07/21/19
07:31
On The Fly
Opening Day: Start-up DouYou becomes China's biggest Wall Street IPO of 2019 »

Drugmaker Genmab raised…

TCEHY

Tencent

$0.00

(0.00%)

MDLA

Medallia

$37.09

(0.00%)

MIRM

Mirum Pharmaceuticals

$13.51

0.17 (1.27%)

FULC

Fulcrum Therapeutics

$12.49

-0.99 (-7.34%)

PHR

Phreesia

$24.01

-1.15 (-4.57%)

GMAB

Genmab

$18.06

-0.14 (-0.77%)

AMK

AssetMark Financial

$27.71

0.39 (1.43%)

ORCC

Owl Rock

$15.51

0.11 (0.71%)

DOYU

DouYu

$10.50

-0.51 (-4.63%)

NOVA

Sunnova Energy

$0.00

(0.00%)

CSTL

Castle Biosciences

$0.00

(0.00%)

WSG

Wanda Sports

$0.00

(0.00%)

LVGO

Livongo Health

$0.00

(0.00%)

HCAT

Health Catalyst

$0.00

(0.00%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 31

    Jul

  • 14

    Aug

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

NFLX

Netflix

$315.10

-10.04 (-3.09%)

07:37
07/20/19
07/20
07:37
07/20/19
07:37
Periodicals
Netflix's problems have only just begun, Barron's says »

Netflix has a problem and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

07:34
07/20/19
07/20
07:34
07/20/19
07:34
Periodicals
Time to aim higher on Target's stock, Barron's says »

As retailers have…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 21

    Aug

  • 19

    Sep

  • 25

    Sep

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, FDX

FedEx

$167.08

1.69 (1.02%)

07:31
07/20/19
07/20
07:31
07/20/19
07:31
Periodicals
FedEx ups game amid e-commerce growth, Barron's says »

It is time to embrace…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

FDX

FedEx

$167.08

1.69 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

07:27
07/20/19
07/20
07:27
07/20/19
07:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

ORCL

Oracle

$57.55

-0.58 (-1.00%)

AZN

AstraZeneca

$40.11

-0.61 (-1.50%)

BMY

Bristol-Myers

$43.32

-0.72 (-1.63%)

LLY

Eli Lilly

$106.75

-1.57 (-1.45%)

GSK

GlaxoSmithKline

$40.97

-0.44 (-1.06%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

MRK

Merck

$81.39

-1.28 (-1.55%)

NVS

Novartis

$93.58

-0.715 (-0.76%)

PFE

Pfizer

$42.78

-0.28 (-0.65%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$41.94

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

  • 02

    Sep

  • 09

    Sep

  • 16

    Sep

  • 16

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 15

    Oct

  • 04

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.